TSRO News Alert Tesaro Inc (TSRO) 36.80 12/25/2014 05:04:21

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tesaro Inc (TSRO) 36.80 $TSRO

Pfizer Licenses Opko's Long-Acting Growth Hormone
at Investor's Business Daily - Mon Dec 15, 11:01AM CST
Biotech Opko Health found a big-pharma partner for its human-growth drug candidate in the form of Pfizer on Monday in a deal that could be worth as much as $570 million. Opko Health (OPK) stock was near 9, up 9% in morning trading -- a more than...
TSRO: 36.80 (+0.57), OPK: 9.63 (+0.21), PFE: 31.42 (-0.03)

RedHill submits MAA for ondansetron
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:38AM CST

INSY: 41.52 (+0.51), TSRO: 36.80 (+0.57), HRTX: 9.75 (+0.02), RDHL: 12.22 (-0.13), GWPH: 68.08 (+1.82), OPK: 9.63 (+0.21), GALE: 1.49 (-0.02)

TESARO and AnaptysBio Expand Immuno-Oncology Collaboration to Include Novel Bispecific Antibody Candidate
GlobeNewswire - Tue Dec 02, 4:14AM CST
--Candidate Will Target Two Undisclosed Immune Checkpoints
TSRO: 36.80 (+0.57)

TESARO to Present at the 2014 Deutsche Bank BioFEST
GlobeNewswire - Tue Nov 25, 4:00PM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at the 2014 Deutsche Bank BioFEST Conference on Tuesday, December 2, 2014 at 4:00 p.m. ET in Boston.
TSRO: 36.80 (+0.57), DB: 30.95 (+0.04)

TESARO to Present at the Nasdaq 31st Investor Program
GlobeNewswire - Tue Nov 25, 7:07AM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Nasdaq 31 Investor Program on Tuesday, December 2, 2014 at 10:15 a.m. GMT in London.
TSRO: 36.80 (+0.57)

Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 2:10PM CST
New data revealed Myriad's (MYGN) myChoice HRD score as an efficient predictor of niraparib sensitivity in patient-derived xenograft models of ovarian cancer
MYGN: 36.50 (+0.28), TSRO: 36.80 (+0.57), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)

TESARO and Myriad Announce Companion Diagnostics Collaboration
GlobeNewswire - Thu Nov 20, 6:45AM CST
TESARO, Inc. (Nasdaq:TSRO) and Myriad Genetics (Nasdaq:MYGN) today announced a collaboration utilizing Myriad's myChoice HRD companion diagnostic (CDx) to identify tumor tissue with a deficiency in homologous recombination. Under the terms of the agreement, TESARO will utilize Myriad's test to enrich the target population for potential responders to niraparib. Myriad will provide testing services and pursue necessary regulatory approvals in support of TESARO's development of niraparib.
MYGN: 36.50 (+0.28), TSRO: 36.80 (+0.57)

'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?
at The Street - Sat Nov 15, 4:00AM CST
The trading panel took a look at gold prices, which climbed 2.3% on Friday, as well as the potential for a pullback in biotech stocks.
AMZN: 303.03 (-3.26), TSRO: 36.80 (+0.57), XBI: 182.62 (+3.44), IBB: 299.80 (+5.12), CELG: 109.60 (+3.48), GILD: 91.29 (+1.84), GLD: 112.77 (+0.03), MCD: 93.83 (-0.39), SLV: 15.09 (+0.05), GDX: 17.77 (+0.47), TWTR: 37.61 (+0.04), AAPL: 112.01 (-0.53), BABA: 105.95 (+0.43)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 4:38PM CST

HK: 1.96 (-0.08), NTES: 101.31 (+0.90), CIG: 4.77 (-0.06), TSRO: 36.80 (+0.57), DDD: 30.54 (-0.64), CLDX: 17.08 (-0.18), SCMP: 13.75 (+0.44), BVN: 9.29 (+0.26), ABGB: 11.90 (unch), SSE: 6.64 (-0.03)

TESARO to Present at the Jefferies 2014 Global Healthcare Conference
GlobeNewswire - Wed Nov 12, 7:00AM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, November 19, 2014 at 11:20 a.m. GMT in London.
TSRO: 36.80 (+0.57)

TESARO's (TSRO) CEO Lonnie Moulder on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 1:31AM CST

TSRO: 36.80 (+0.57)

Tesaro beats 3Q profit forecasts
Automated Insights - Thu Nov 06, 4:04AM CST
WALTHAM, Mass. (AP) _ Tesaro Inc. (TSRO) on Thursday reported a third-quarter loss of $36.2 million.
TSRO: 36.80 (+0.57)

Tesaro beats by $0.03
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:07PM CST

TSRO: 36.80 (+0.57)

TESARO Announces Third-Quarter 2014 Operating Results
GlobeNewswire - Wed Nov 05, 3:36PM CST
-- Oral Rolapitant New Drug Application (NDA) Accepted for Review by U.S. FDA
TSRO: 36.80 (+0.57)

Tesaro reports November 5
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:34PM CDT

TSRO: 36.80 (+0.57)

Tesaro to Announce Third-Quarter 2014 Financial Results on November 5, 2014
GlobeNewswire - Wed Oct 22, 3:01PM CDT
TESARO, Inc. (Nasdaq:TSRO) will announce its third-quarter 2014 financial results on Wednesday, November 5, 2014, after the close of the U.S. financial markets. TESARO's senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on November 5, 2014 to discuss the Company's results in greater detail.
TSRO: 36.80 (+0.57)

TESARO Announces Closing of $201.25 Million Public Offering of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise of the Underwriters' Option to Purchase Additional Notes
GlobeNewswire - Mon Sep 29, 3:01PM CDT
TESARO, Inc. (Nasdaq:TSRO) announced today the closing of its previously announced underwritten public offering of $201.25 million aggregate principal amount of its 3.00% convertible senior notes due 2021 (the "notes" , including the notes issued pursuant to the full exercise of the underwriters' option to purchase up to $26.25 million aggregate principal amount of additional notes on the same terms and conditions. As a result, aggregate net proceeds to TESARO, after deducting the underwriting discount and estimated offering expenses payable by TESARO, will be approximately $194.71 million.
TSRO: 36.80 (+0.57), DB: 30.95 (+0.04)

Weakness Seen in Tesaro, Inc. (TSRO): Stock Tumbles 9.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 7:54AM CDT
Make sure to keep a close watch on Tesaro in the near future, and especially on earnings estimates following the recent slump.
TSRO: 36.80 (+0.57)

TESARO Announces Pricing of $175 Million of 3.00% Convertible Senior Notes Due 2021
GlobeNewswire - Tue Sep 23, 9:40PM CDT
TESARO, Inc. (Nasdaq:TSRO) announced today the pricing of $175 million aggregate principal amount of its 3.00% convertible senior notes due 2021 (the "notes" in an underwritten public offering. The size of the offering was increased from the previously announced aggregate principal amount of $165 million. TESARO has granted the underwriters a 30-day option to purchase up to $26.25 million aggregate principal amount of additional notes on the same terms and conditions to cover over-allotments. The offering is expected to close on or about September 29, 2014, subject to customary closing conditions.
TSRO: 36.80 (+0.57), DB: 30.95 (+0.04)

Nasdaq stocks posting largest percentage decreases
AP - Tue Sep 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
UBNT: 31.30 (+0.14), TSRO: 36.80 (+0.57), WATT: 9.46 (+1.49), MLAB: 79.70 (+1.10), NVC.TO: 7.61 (+0.11), NVCN: 6.60 (unch), PBSK: 14.99 (+0.21)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Union Pacific Faces $98.8 Million Arbitration Tab

Updated Category News Views 181

A Missed Schedule Promise Got Very Expensive Railroad labor disputes can look like paperwork until the bill lands with a thud. Union Pacific is facing an estimated $98.8 million arbitration payout after a Special Board of Adjustments found that the carrier failed to implement a negotiated scheduling benefit for locomotive engineers. That is not loose change, and it is the...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 100

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 48

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 103

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 61

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 89

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 104

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Urged to Review Lawsuit Against Cepton, Inc. (CPTN)

Updated Category News Views 203

Class Action Against Cepton, Inc. Unveiled Recent developments have raised significant concerns for investors of Cepton, Inc. (NASDAQ: CPTN) following revelations of a class action lawsuit. Leading national plaintiffs' law firm Berger Montague has stepped in to help those impacted. The lawsuit focuses on investors who bought or sold Cepton shares during a specified...

Continue Reading
Exploring Uber Technologies: A Strategic Trade Perspective

Updated Category News Views 172

Uber Technologies Inc.'s Current Market Position Recently, ride-sharing giant Uber Technologies, Inc. (NYSE: UBER) experienced a notable increase in its market value. This uplift followed an innovative announcement regarding the capability for riders to book an Avride robotaxi, showcasing the evolution of autonomous mobility solutions. In the past five trading days, UBER...

Continue Reading
Celebrating Diversity: Winners of the Art Limitless Contest

Updated Category News Views 168

Celebrating the Art Limitless Competition Winners In the heart of artistic innovation, BE OPEN has unveiled the winners of the Art Limitless competition, an initiative celebrating inclusivity and diversity in the arts. This remarkable program strives to empower artists with disabilities, showcasing their work while inspiring broader societal awareness. What is Art...

Continue Reading
Certuity Welcomes Constantine Hatzivassiliou as New Partner

Updated Category News Views 246

Certuity Welcomes Constantine Hatzivassiliou as New Partner Certuity, a leading multi-family office dedicated to serving high-net-worth individuals and families, is thrilled to announce the promotion of Managing Director Constantine Hatzivassiliou to Partner. This significant advancement not only reflects Hatzivassiliou's commitment to the firm but also the invaluable...

Continue Reading
Sila Realty Trust, Inc.'s Key Updates on Q3 2024 Earnings

Updated Category News Views 124

Sila Realty Trust, Inc. Announces Upcoming Q3 Earnings Release Sila Realty Trust, Inc. (NYSE: SILA) recently made an announcement regarding its anticipated financial results for the third quarter of 2024. The company will release these earnings on a Tuesday morning, just before the market opens. This timely communication reflects Sila's commitment to transparency and...

Continue Reading